Other languages Indivior PLC Nasdaq

Equities

Real-time Estimate Cboe BZX Other stock markets 12:15:51 2024-06-03 EDT			5-day change	1st Jan Change
18.34 ^USD	+0.08%		-0.87%	+19.97%

05-23	Indivior Confirms FY24 Outlook	MT
05-23	Transcript : Indivior PLC - Shareholder/Analyst Call

Indivior Confirms FY24 Outlook	05-23
Transcript : Indivior PLC - Shareholder/Analyst Call	05-23
Indivior : Special Resolution Passed at the 2024 General Meeting Held on May 23, 2024	05-23
Indivior reconfirms 2024 outlook amid NY-listing decision	05-23
Indivior plc Reaffirms Revenue Guidance for the Year 2024	05-23
Indivior to Host Analyst Teach-in Event in New York City; Reconfirms Full Year 2024 Guidance	05-23
The latest transactions by star managers	05-21
Indivior PLC Announces Board Committee Changes	05-10
Indivior : Notice of 2024 General Meeting	05-03
Deutsche Bank Kicks Off Indivior Coverage at Buy	05-03
Jefferies cuts AJ Bell; Deutsche likes ConvaTec	05-03
Transcript : Indivior PLC, Q1 2024 Earnings Call, Apr 25, 2024	04-25
London-listed Indivior Confirms Plan for Primary Listing in US	04-25
Indivior Seeks Shareholder Nod for Listing in the United States	04-25
UK-listed drugmaker Indivior seeks shareholder nod for US listing	04-25
Indivior shares down despite profit boost on planned shift to New York	04-25
Indivior Reports Higher Q1 Net Income, Net Revenue	04-25
Tranche Update on Indivior PLC's Equity Buyback Plan announced on November 17, 2023.	04-25
Indivior plc Reconfirms Earnings Guidance for 2024	04-25
Indivior PLC Reports Earnings Results for the First Quarter Ended March 31, 2024	04-25

No results for this search